ACET 0.95 (-9.52%)
US0070021086BiotechnologyBiotechnology

Adicet Bio (ACET) Stock Highlights

0.95 | -9.52%
2024-11-16 05:59:43
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. The company is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients.

Statistics

Range Today
0.93 1.04
Volume Today 1.1M
Range 1 Year
1.03 3.77
Volume 1 Year 258.99M
Range 3 Year
1.03 21.87
Volume 3 Year 596.58M
Range 10 Year
1.03 147.679
Volume 10 Year 795.65M

Highlights

Market Capitalization 107.95M (small)
Floating Shares 62.1M
Current Price 0.95
Price To Earnings -0.54
Price To Book 0.33
Earnings Per Share -2.48
Payout Ratio 0%

Performance

Latest -9.52%
1 Month -31.16%
3 Months -32.14%
6 Months -32.62%
1 Year -20.17%
3 Years -90.21%
5 Years -91.62%
10 Years -99.27%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.